XML 18 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Follow On Public Offering
Initial Public Offering
At The Market Offering
Private Placement
Redeemable Convertible Preferred Stock
Common Stock
Common Stock
Follow On Public Offering
Common Stock
Initial Public Offering
Common Stock
At The Market Offering
Common Stock
Private Placement
Additional Paid-In Capital
Additional Paid-In Capital
Follow On Public Offering
Additional Paid-In Capital
Initial Public Offering
Additional Paid-In Capital
At The Market Offering
Additional Paid-In Capital
Private Placement
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Redeemable convertible preferred stock, beginning balance at Dec. 31, 2018           $ 138,391                        
Redeemable convertible preferred stock, beginning balance, shares at Dec. 31, 2018           13,139,794                        
Conversion of redeemable convertible preferred stock into common stock           $ (138,391)                        
Conversion of redeemable convertible preferred stock into common stock, shares           (13,139,794)                        
Beginning balance at Dec. 31, 2018 $ (48,948)                     $ 1,599         $ (31) $ (50,516)
Beginning balance, shares at Dec. 31, 2018             1,335,690                      
Conversion of redeemable convertible preferred stock into common stock 138,391           $ 1         138,390            
Conversion of redeemable convertible preferred stock into common stock, shares             13,139,794                      
Issuance of common stock, net of issuance cost     $ 50,247           $ 1         $ 50,246        
Issuance of common stock, net of issuance costs, shares                 5,750,000                  
Issuance of common stock upon exercise of stock options 307                     307            
Issuance of common stock upon exercise of stock options, shares             135,563                      
Early exercised common stock options, shares             2,112                      
Repurchase of early exercised shares, shares             (23,698)                      
Vesting of early exercised common stock options and restricted stock 114                     114            
Stock-based compensation 2,168                     2,168            
Other comprehensive income (loss) 96                               96  
Net loss (41,975)                                 (41,975)
Ending balance at Dec. 31, 2019 100,400           $ 2         192,824         65 (92,491)
Ending balance, shares at Dec. 31, 2019             20,339,461                      
Issuance of common stock, net of issuance cost   $ 100,664   $ 6,582 $ 19,988     $ 1         $ 100,663   $ 6,582 $ 19,988    
Issuance of common stock, net of issuance costs, shares               7,166,667   410,896 1,333,333              
Issuance of common stock upon exercise of stock options 1,202                     1,202            
Issuance of common stock upon exercise of stock options, shares             256,583                      
Employee stock purchase plan (ESPP) purchase $ 326                     326            
Employee stock purchase plan (ESPP) purchase, shares             40,794                      
Repurchase of early exercised shares, shares (10,518)           (10,518)                      
Vesting of early exercised common stock options and restricted stock $ 56                     56            
Stock-based compensation 3,609                     3,609            
Other comprehensive income (loss) (58)                               (58)  
Net loss (34,495)                                 (34,495)
Ending balance at Dec. 31, 2020 198,274           $ 3         325,250         7 (126,986)
Ending balance, shares at Dec. 31, 2020             29,537,216                      
Issuance of common stock, net of issuance cost   $ 85,990   $ 57,263       $ 1         $ 85,989   $ 57,263      
Issuance of common stock, net of issuance costs, shares               5,333,333   3,407,872                
Issuance of common stock upon exercise of stock options 1,510                     1,510            
Issuance of common stock upon exercise of stock options, shares             211,900                      
Employee stock purchase plan (ESPP) purchase $ 697                     697            
Employee stock purchase plan (ESPP) purchase, shares             50,037                      
Repurchase of early exercised shares, shares 0                                  
Repurchase of unvested restricted stock             (7,313)                      
Vesting of early exercised common stock options and restricted stock $ 24                     24            
Stock-based compensation 8,237                     8,237            
Other comprehensive income (loss) (719)                               (719)  
Net loss (49,762)                                 (49,762)
Ending balance at Dec. 31, 2021 $ 301,514           $ 4         $ 478,970         $ (712) $ (176,748)
Ending balance, shares at Dec. 31, 2021             38,533,045